Kupando raises €13m to push TLR4/7 agoni... Kupando has raised €13m in Series A financing co-led by Remiges Ventures and LifeCare Partners to initiate clinical development of KUP101. more ➔
DAMAN P/S enters personal RA medicine proj...Danish AI health app developer DAMAN P/S has entered the €12m EU-funded Squeeze project, that aims to find stratification biomarkers for DMARDs in rheumatoid arthritis (RA). more ➔
AI specialist Quinten Health bags €14m f... Quinten Groups French healthcare arm Quinten Health has closed a financing round to advance disease modeling platforms and virtual twins in real-world. more ➔
Bavarian Nordic expands vaccine contract b...Bavarian Nordic A/S has expand its smallpox contract signed with the Canadian PHAC in June from $56m to $470m including $180m in contract options. more ➔
Genfit swallows Versantis in €105m dealThrough the acquisition of Versantis for €40m upfront and further €65m in milestones, Genfit SA has added three clinical and preclinical candidates to its liver drug portfolio. more ➔
Food specialist Standing Ovation SA raises...Foodtech startup Standing Ovation SA has closed an oversubscribed €12m Series A financing round led by Astanor Ventures. more ➔
HeartBeat.bio inks partnership with Molecu...HeartBeat.bio and Molecular Devices announce collaboration to automate and scale cardiac organoids for high-throughput drug discovery screening more ➔
Mobile app recognises COVID-19 infectionDutch researchers report they could detect a COVID-19 infection with better sensitivity than antigen tests by a mobile app that uses AI to analyse voice recordings. more ➔
Pleco Therapeutics raises €17.3m in Seri...Dutch Pleco Therapeutics BV has raised €17.3m in a Series A financing to push its lead candidate in acute myeloid leukaemia to market approval. more ➔
Emergence Therapeutics licences Synaffix p...Synaffix B.V. and Emergence Therapeutics AG have entered into a licensing agreement of up to $360m to find ADCs directed against target molecules from Emergence. more ➔
